We measure our success in the value of human life.

FIT Biotech

FIT Biotech is an innovative medical biotechnology company engaged in the development and commercialisation of its proprietary Gene Transport Unit (GTU®) technology and GTU® product applications in DNA vaccination as well as in immuno- and gene therapies.

News and Events

Lehdistötiedote 15.10.2014

Fit Biotech ja Icosagen taistelussa Ebola-infektiota vastaan
Lue lisää

Press Release October-15-2014

Fit Biotech and Icosagen fighting against Ebola infection
Read more

In Memoriam

FIT Biotech pays tribute to Professor Joep Lange
Read more

Research and Development

Research & Development

FIT Biotech's most important R&D activity since the start of its operations has been the development of an HIV vaccine.

 

R&D Publications